Skip to main content

Articles

Page 6 of 16

  1. Authors: KA Phillips, RL Milne, MA Rookus, D Goldgar, M Friedlander, SA McLachlan, S Buys, AC Antoniou, K Birch, MB Terry, DF Easton, P Weideman, M Daly, N Andrieu, EM John, MJ Hooning…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A11
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  2. Authors: Allison M Burton, Susan K Peterson, Salma K Marani, Sally W Vernon, Christopher I Amos, Marsha L Frazier, Patrick M Lynch and Ellen R Gritz
    Citation: Hereditary Cancer in Clinical Practice 2011 9(Suppl 1):P5
    Content type: Poster presentation Published on:

    This article is part of a Supplement: Volume 9 Supplement 1

  5. Although the probability of both parents being affected by BRCA1 mutations is not negligible, such families have not been systematically described in the literature. Here we present a large breast-ovarian canc...

    Authors: Anna P Sokolenko, Dmitry A Voskresenskiy, Aglaya G Iyevleva, Elena M Bit-Sava, Nadezhda I Gutkina, Maxim S Anisimenko, Nathalia Yu Sherina, Nathalia V Mitiushkina, Yulia M Ulibina, Olga S Yatsuk, Olga A Zaitseva, Evgeny N Suspitsin, Alexandr V Togo, Valery A Pospelov, Sergey P Kovalenko, Vladimir F Semiglazov…
    Citation: Hereditary Cancer in Clinical Practice 2009 7:2
    Content type: Case report Published on:

  6. The molecular diagnostics of genetically conditioned disorders is based on the identification of the mutations in the predisposing genes. Hereditary cancer disorders of the gastrointestinal tracts are caused b...

    Authors: Andrzej Pławski, Marta Podralska and Ryszard Słomski
    Citation: Hereditary Cancer in Clinical Practice 2007 5:195
    Content type: Research Published on:

  8. Authors: Magdalena Muszyńska, Grzegorz Sukiennicki, Tomasz Huzarski, Jacek Gronwald, Cezary Cybulski, Tadeusz Dębniak, Aleksandra Tołoczko-Grabarek, Oleg Ashuryk, Anna Jakubowska, Antoni Morawski and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A17
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 10 Supplement 3

  10. Authors: P Whiley, LC Walker, M De LA Hoya, B Wappenschmidt, A Becker, A Blanco, MJ Blok, MA Caligo, C Chatfield, F Couch, O Diez, L Fachal, L Guidugli, S Gutiérrez Enríquez, T Hansen, C Houdayer…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A87
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  11. Authors: Szymon Hryhorowicz, Katarzyna Ziemnicka, Marta Kaczmarek-Rys, Justyna Hoppe-Golebiewska, Andrzej Plawski, Marzena Skrzypczak-Zielinska, Monika Golab, Malgorzata Szkudlarek, Batlomiej Budny, Marek Ruchala and Ryszard Slomsk
    Citation: Hereditary Cancer in Clinical Practice 2015 13(Suppl 1):A15
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 13 Supplement 1

  16. Authors: S Sawyer, S Boyle, MA Young, S Kovalenko, R Doherty, J McKinley, K Alsop, M Rehfisch, S Macaskill, A Ha, V Beshay, G Lindeman, M Harris, S Fox, G Mitchell and P James
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A89
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  19. The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of ...

    Authors: Nadezhda Yu Krylova, Oksana S Lobeiko, Anna P Sokolenko, Aglaya G Iyevleva, Maxim E Rozanov, Natalia V Mitiushkina, Madina M Gergova, Tatiana V Porhanova, Adel F Urmancheyeva, Sergey Ya Maximov, Alexandr V Togo and Evgeny N Imyanitov
    Citation: Hereditary Cancer in Clinical Practice 2006 4:193
    Content type: Research Published on:

    The Erratum to this article has been published in Hereditary Cancer in Clinical Practice 2007 5:56

  22. Authors: DD Buchanan, AK Win, R Walters, MD Walsh, M Clendenning, B Nagler, E Pavluk, SA Pearson, C Rosty, J Maskiell, JL Hopper, MA Jenkins and JP Young
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A23
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  24. Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by...

    Authors: Marzena Skrzypczak, Marta Podralska, Wolfram Heinritz, Ursula G Froster, Daniel Lipiński, Ryszard Słomski and Andrzej Pławski
    Citation: Hereditary Cancer in Clinical Practice 2006 4:43
    Content type: Research Published on:

  29. Little is known about the aetiology of chronic lymphocytic leukaemia (CLL). The family medical history is a "genomic tool" capturing interactions of genetic susceptibility, shared environment and common behavi...

    Authors: Walter Weber, Patrick F. Maurer, Jacqueline Estoppey and Marcel Zwahlen
    Citation: Hereditary Cancer in Clinical Practice 2007 5:210
    Content type: Research Published on:

  32. Authors: Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Huzarski, Jacek Gronwald, Cezary Cybulski, Tadeusz Dębniak, Aleksandra Tołoczko-Grabarek, Oleg Oszurek, Anna Jakubowska, Antoni Morawski and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A5
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 10 Supplement 4

  36. Mutations in FLCN cause Birt-Hogg-Dubé syndrome, an autosomal dominant disorder notable for development of cutaneous fibrofolliculomas or trichodiscomas, a variety of renal tumors, and spontaneous pneumothorax du...

    Authors: Noralane M Lindor, Jan Kasperbauer, Jean E Lewis and Mark Pittelkow
    Citation: Hereditary Cancer in Clinical Practice 2012 10:13
    Content type: Case report Published on:

  39. The BRCA1/2 genes account for a significant portion of hereditary breast and ovarian cancers and they are especially prevalent in the Ashkenazi Jewish population. Women who have a mutation can prevent breast a...

    Authors: Katherine H Saunders, Shivani Nazareth and Peter I Pressman
    Citation: Hereditary Cancer in Clinical Practice 2011 9:3
    Content type: Case report Published on:

  44. Authors: Monica Ganzinelli, Enilze Ribeiro, Ramona Bertoni, Letizia Bazzola, Daniele Andreis, Alberto Bottini, Roberto Giardini, Camillo Rossi, Giovanna Damia and Daniele Generali
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A37
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  47. BRCA1 and BRCA2 mutations contribute to both breast cancer and ovarian cancer worldwide. In Poland approximately 4% of patients with breast cancers and 10% of patients with ovarian cancer carry a mutation in BRCA...

    Authors: Jacek Gronwald, Cezary Cybulski, Tomasz Huzarski, Anna Jakubowska, Tadeusz Debniak, Marcin Lener, Steven A Narod and Jan Lubinski
    Citation: Hereditary Cancer in Clinical Practice 2023 21:9
    Content type: Comment Published on:

  49. The majority of hereditary breast and ovarian cancers can be accounted for by germline mutations in the BRCA1 and BRCA2 genes. Genetic counselling and testing in high-risk patients in the Czech Republic began ...

    Authors: Lenka Foretova, Katarina Petrakova, Marketa Palacova, Renata Kalabova, Marie Navratilova, Miroslava Lukesova, Petra Vasickova, Eva Machackova, Zdenek Kleibl and Petr Pohlreich
    Citation: Hereditary Cancer in Clinical Practice 2006 4:3
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    1.7 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    0.634 - SNIP (Source Normalized Impact per Paper)
    0.526 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    131 days submission to accept (Median)

    2023 Usage 
    394,813 downloads
    196 Altmetric mentions

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287